Ishita Drugs and Industries Limited (ISHITADR.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹70.53 (+0.00%) as of
Key statistics
- Market cap
- 210.91M
- P/E (TTM)
- 29.89
- EPS (TTM)
- 2.36
- Dividend yield
- 0.00%
- 52-week range
- 66.00 – 90.85
- Beta
- -0.08
- Revenue (TTM)
- 124.05M
- Profit margin
- 5.69%
- Volume
- 311.00
About Ishita Drugs and Industries Limited
Ishita Drugs and Industries Limited engages in the manufacture and sale of active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers Active Pharma Ingredients, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates and fine chemicals. The company was founded in 1972 and is based in Ahmedabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Ahmedabad, India
- Employees
- 17
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- MT EDUCARE LTD (MTEDUCARE.NS)
- DB (INTERNATIONAL) STOCK BROKE (DBSTOCKBRO.BO)
- FUTURE MARKET NETWORKS LTD. (FMNL.BO)
- AMRAPALI INDUSTRIES LTD. (AMRAPLIN.BO)
- AGRI- TECH (INDIA) LTD (AGRITECH.BO)
- Nitin Castings Limited (NITINCAST.BO)
- DSP BSE Sensex ETF (SENSEXADD.BO)
- AMBICA AGARBATHIES & AROMA IND (AMBICAAGAR.BO)